KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Equity Average (2016 - 2025)

Historic Equity Average for Dynavax Technologies (DVAX) over the last 15 years, with Q3 2025 value amounting to $514.2 million.

  • Dynavax Technologies' Equity Average fell 2235.0% to $514.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $514.2 million, marking a year-over-year decrease of 2235.0%. This contributed to the annual value of $609.4 million for FY2024, which is 131.21% up from last year.
  • According to the latest figures from Q3 2025, Dynavax Technologies' Equity Average is $514.2 million, which was down 2235.0% from $512.6 million recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' Equity Average registered a high of $662.1 million during Q3 2024, and its lowest value of $75.5 million during Q3 2021.
  • For the 5-year period, Dynavax Technologies' Equity Average averaged around $447.1 million, with its median value being $540.8 million (2022).
  • Per our database at Business Quant, Dynavax Technologies' Equity Average soared by 68778.46% in 2021 and then crashed by 2235.0% in 2025.
  • Dynavax Technologies' Equity Average (Quarter) stood at $145.0 million in 2021, then surged by 273.03% to $540.8 million in 2022, then grew by 13.44% to $613.5 million in 2023, then increased by 4.18% to $639.1 million in 2024, then fell by 19.55% to $514.2 million in 2025.
  • Its Equity Average was $514.2 million in Q3 2025, compared to $512.6 million in Q2 2025 and $563.9 million in Q1 2025.